Amesite (NASDAQ: AMST), a leading artificial intelligence (“AI”) software company offering a cloud-based learning platform for business and education markets, has announced that users of its NurseMagic app come from all 50 states and from six nations. The app has only been released for eight weeks, following a beta period of availability, so that wide usage represents the app’s value. According to the company, the app has registered 830% user growth month on month, from June 2024 to July 2024. NurseMagic delivers all key types of documentation, training, learning and support for patient communication and is used by at least 27 different nursing and healthcare-related professions. The company noted that the app is being used for assistance in creating a wide variety of required reports, including narrative and SOAP notes for progress and shift updates, behavioral and home-health use cases such as detailed patient assessments and individualized care plans, and incident reports and admission records. One user stated that the app cuts the work that nurses have to do during a shift by over a third. “The queries we are seeing from around the U.S. and globe show just how much nursing professionals do for society,” said Amesite CEO Dr. Ann Marie Sastry in the press release. “Their challenges are at times heartbreaking, eye-opening, and most of all, inspiring. From communicating with people with serious diagnoses in other languages, to explaining medical procedures, to getting a jumpstart on essential documentation, we believe that the app is becoming an essential tool for these professionals.”

To view the full press release, visit https://ibn.fm/r01XO

About Amesite Inc.

Amesite is a pioneering technology company specializing in the development and marketing of business-to-consumer (“B2C) and business-to-business (“B2B”) artificial intelligence (“AI”)-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. The company’s recently launched NurseMagic(TM) is a mobile app offering AI tools to assist nurses in providing patient care including nurse notes and medication information and professional career assistance. Preacto(TM) (beta) is a personal safety application designed to provide real-time alerts and guidance in the event of an emergency situations, including active shooter response. For more information about the company, please visit www.Amesite.io.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN